scispace - formally typeset
W

Willy Rozenbaum

Researcher at Centre national de la recherche scientifique

Publications -  108
Citations -  11476

Willy Rozenbaum is an academic researcher from Centre national de la recherche scientifique. The author has contributed to research in topics: Viral load & Didanosine. The author has an hindex of 35, co-authored 104 publications receiving 11173 citations.

Papers
More filters
Journal ArticleDOI

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

TL;DR: From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.
Journal Article

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

TL;DR: It is concluded that this virus as the previous HTVL isolate belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in human and may be involved in several pathological syndromes, including AIDS.
Journal ArticleDOI

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

TL;DR: The altered differentiation status of peripheral adipocytes in HIV-1-infected patients with antiretroviral-induced lipoatrophy is associated with greatly reduced SREBP1c expression, which may lead to metabolic alterations such as insulin resistance.
Journal ArticleDOI

Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.

TL;DR: Age was significantly associated with different phenotypes of lipodystrophy and metabolic alterations, but body-mass index, CD4(+) cell count, and type of nucleoside reverse-transcriptase inhibitor or PI received were not constantly associated with these changes.
Journal ArticleDOI

Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome.

TL;DR: Assays of infectivity showed that HPA 23 was inhibiting virus replication without killing virus infected cells, the first demonstration of inhibition of the growth of LAV in AIDS patients, and it remains to be established whether antiviral drugs can cure AIDS.